News|Articles|November 15, 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Author(s)Phenomenex, Inc.
Fact checked by: Phenomenex, Inc.
Learn the latest techniques for improved chromatographic performance and throughput of AAV analysis.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Oct. 13, 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
